300 episodes

Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.

GRACEcast GRACEcast

    • Medicine

Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.

    • video
    FCR vs. BR - Is One Better?

    FCR vs. BR - Is One Better?

    Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (bendamustine and rituximab), is a relatively newer therapy, which had been studied in a couple of phase two trials - smaller single arm trials and look to be promising.

    • 4 min
    • video
    Basics of Small Cell Lung Cancer

    Basics of Small Cell Lung Cancer

    Lung Cancer Video Library ASCO 2016 Rachel Sanborn Basics of Small Cell Lung Cancer

    • 4 min
    • video
    Adjuvant Chemotherapy for Elderly and Frail Patients

    Adjuvant Chemotherapy for Elderly and Frail Patients

    Lung Cancer Video Library ASCO 2016 - Rachel Sanborn - Adjuvant Chemotherapy for Elderly and Frail Patients

    • 6 min
    • video
    Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

    Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

    Lung Cancer Video Library - Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

    • 5 min
    • video
    New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis

    New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis

    GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.

    Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss new trials of targeting therapies used to treat leptomeningeal carcinomatosis.

    • 4 min
    • video
    ASCO 2016 LC RT Vid 8 - Promising Early Results for Treatments

    ASCO 2016 LC RT Vid 8 - Promising Early Results for Treatments

    GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.
    Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss promising early results for treatments targeting new mutations.

    • 4 min

Top Podcasts In Medicine

Listeners Also Subscribed To

More by GRACEcast